Interestingly, the ovarian cancer cell line OVK18, which showed the highest UBQLN4 mRNA levels in CCLE had the highest sensitivity to Olaparib, despite having the lowest sensitivity to cisplatin treatment (Figure 4C,F). The gene discussed is UBQLN4; the disease is ovarian carcinoma.